To me the stock has been trading like a secondary is in the works. IMHO... The stock ran up on some upgrades and those COULD be the potential underwriters... Unless there is a buy out the company will need to raise money to fund a large sales force...mfg....marketing/advertising.....etc. Maybe not tomorrow, but down the road pretty soon... I went through a going it alone FDA approved drug company and it ended up in disaster, so a buyout would be far better IMHO for shareholders.... Sold in the high 16's from buys in the 7's,
and will likely re-enter the stock once the issue of funding is alot clearer to me.... Love the antibiotic though!GLTALs!
Golong, I think you are right. I think a secondary is eminent. I was thinking they would do it at $14, awhile back. ( (Same price they did the first offering on HGSI, some year's ago.) Now I am thinking "$16."
sorry Golongin but I don't agree ... Look at TTPH : same story ... biotech and especially antibiotics got beaten up ! IMHO this is a general negative sentiment and not related to DRTX and a possible secondary.